2022
DOI: 10.1002/joa3.12714
|View full text |Cite
|
Sign up to set email alerts
|

JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 1,036 publications
(2,866 reference statements)
0
4
0
Order By: Relevance
“…Atrial fibrillation (AF) increases the risk of cardiogenic stroke fivefold 1 . Anticoagulation is highly effective in preventing stroke in patients with AF, with risk stratification based on the CHADS 2 score determining the indication 2 . However, given that stroke has been reported even in patients with a CHADS 2 score of 0, 3 other risk factors should also be evaluated when considering the indication for oral anticoagulants (OACs) 2 .…”
Section: Introductionmentioning
confidence: 99%
“…Atrial fibrillation (AF) increases the risk of cardiogenic stroke fivefold 1 . Anticoagulation is highly effective in preventing stroke in patients with AF, with risk stratification based on the CHADS 2 score determining the indication 2 . However, given that stroke has been reported even in patients with a CHADS 2 score of 0, 3 other risk factors should also be evaluated when considering the indication for oral anticoagulants (OACs) 2 .…”
Section: Introductionmentioning
confidence: 99%
“…[3][4][5][6] Many guidelines recommend oral anticoagulation therapy for patients with AF at elevated risk of stroke. [7][8][9] The data from the Swedish Riksstroke registry of >94 000 strokes have helped identify the major gaps in prevention of AFrelated strokes, which represent 33% of all ischemic strokes. 10,11 In 9% of all strokes, the presence of AF is not known prior to stroke.…”
Section: Introductionmentioning
confidence: 99%
“…AF is associated with a high relative risk of dementia, stroke, major adverse cardiac events, and all‐cause mortality 3–6 . Many guidelines recommend oral anticoagulation therapy for patients with AF at elevated risk of stroke 7–9 …”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…The Japanese Society of Hypertension Guidelines for the Management of Hypertension recommend the use of betablockers in patients with ischemic heart disease and known AF, but not as first-line agents in non-AF hypertensive patients, and they recommend the use of renin-angiotensin system inhibitors for hypertensive heart disease [8]. The Japanese Circulation Society/The Japanese Heart Rhythm Society guidelines indicate the use of beta-blockers for symptomatic atrial premature contractions in Class IIa [11]. Multiple atrial premature contractions are associated not only with the development of AF but also with cardiovascular mortality [12], and beta-blockers for atrial premature contractions have been shown to be effective in reducing AF [13].…”
mentioning
confidence: 99%